Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That’s made them easier to access, but it’s also introduced new potential risks for people recovering from eating disorders like anorexia.

On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that could harm them.

Read more: The Weight-Loss Drug Gold Rush Has a Dangerous Prescription Problem

Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That&rsquo;s made them easier to access, but it&rsquo;s also introduced new potential risks for people recovering from eating disorders like anorexia.
On today&rsquo;s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she&rsquo;s learned about the ways telehealth can make it easier for people to get prescriptions that could harm them.
Read more: <a href="https://www.bloomberg.com/news/features/2024-12-16/weight-loss-drugs-are-too-easily-prescribed-to-people-with-anorexia?srnd=undefined">The Weight-Loss Drug Gold Rush Has a Dangerous Prescription Problem</a>

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

Big Take

The Weight-Loss Drug Boom’s Prescription Problem

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a27ac325-c1d2-4985-80d7-b24f0130c387/transcript

Advertisement